Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2008 2
2009 1
2010 1
2011 1
2012 1
2013 1
2014 3
2017 1
2018 2
2019 4
2020 1
2021 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
The following terms were ignored: %, %, %, %
The following terms were not found in PubMed: 22Animal, 5BMesh
Page 1
Assessment of oligometastasis status of prostate cancer following combined robot-assisted radical prostatectomy and androgen deprivation versus androgen deprivation therapy alone using PSA percentage decline rate.
Li X, Xi H, Cheng X, Yu Y, Zhang C, Wang G, Zhou X. Li X, et al. Front Endocrinol (Lausanne). 2023 Feb 9;14:1123934. doi: 10.3389/fendo.2023.1123934. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36843605 Free PMC article.
OBJECTIVE: To compare the tumor control in prostate cancer patients with oligo-metastasis following combined robot-assisted radical prostatectomy and androgen deprivation versus androgen deprivation therapy alone based on total prostate-specific antigen (tPSA) asses …
OBJECTIVE: To compare the tumor control in prostate cancer patients with oligo-metastasis following combined robot-assisted radical p …
Training family to assist with physiotherapy for older people transitioning from hospital to the community: a pilot randomized controlled trial.
Lawler K, Shields N, Taylor NF. Lawler K, et al. Clin Rehabil. 2019 Oct;33(10):1625-1635. doi: 10.1177/0269215519853874. Epub 2019 Jun 6. Clin Rehabil. 2019. PMID: 31169029 Clinical Trial.
OBJECTIVE: To investigate the safety and effectiveness of augmenting physiotherapy with family-assisted therapy, to inform a future, fully powered trial. DESIGN: Parallel pilot randomized controlled trial. ...The experimental group (n = 17) received usual physiother …
OBJECTIVE: To investigate the safety and effectiveness of augmenting physiotherapy with family-assisted therapy, to inform a f …
Vacuum-Assisted Closure for the Treatment of Deep Sternal Wound Infection After Pediatric Cardiac Surgery.
Sherman G, Shulman-Manor O, Dagan O, Livni G, Scheuerman O, Amir G, Frenkel G, Levy I. Sherman G, et al. Pediatr Crit Care Med. 2020 Feb;21(2):150-155. doi: 10.1097/PCC.0000000000002131. Pediatr Crit Care Med. 2020. PMID: 31568260
OBJECTIVES: Vacuum-assisted closure is being increasingly used to treat deep sternal wound infection following cardiac surgery, but most of the data refer to adults. This study investigated the safety and efficacy of vacuum-assisted closure in pediatric patients. DE …
OBJECTIVES: Vacuum-assisted closure is being increasingly used to treat deep sternal wound infection following cardiac surgery, but m …
Factors Associated With Health-Related Quality of Life 2 Years After Left Ventricular Assist Device Implantation: Insights From INTERMACS.
Grady KL, Fazeli PL, Kirklin JK, Pamboukian SV, White-Williams C. Grady KL, et al. J Am Heart Assoc. 2021 Jul 20;10(14):e021196. doi: 10.1161/JAHA.121.021196. Epub 2021 Jul 9. J Am Heart Assoc. 2021. PMID: 34238018 Free PMC article.
We sought to determine whether preimplant intended goal of LVAD therapy (heart transplant candidate [short-term group], uncertain heart transplant candidate [uncertain group], and heart transplant ineligible [long-term group]) and other variables were related to HRQOL 2 ye …
We sought to determine whether preimplant intended goal of LVAD therapy (heart transplant candidate [short-term group], uncertain hea …
Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors: N-Functionalization Determines the Multitarget Anti-Alzheimer's Activity Profile.
Makhaeva GF, Kovaleva NV, Boltneva NP, Rudakova EV, Lushchekina SV, Astakhova TY, Serkov IV, Proshin AN, Radchenko EV, Palyulin VA, Korabecny J, Soukup O, Bachurin SO, Richardson RJ. Makhaeva GF, et al. Molecules. 2022 Feb 4;27(3):1060. doi: 10.3390/molecules27031060. Molecules. 2022. PMID: 35164325 Free PMC article.
The lead compounds 3a-c exhibited an IC(50)(AChE) = 2.9-1.4 M, IC(50)(BChE) = 0.13-0.067 M, and 14-18% propidium displacement at 20 muM. Kinetic studies of compounds 3a and 5d indicated mixed-type reversible inhibition. Molecular docking revealed favorable poses in both ca …
The lead compounds 3a-c exhibited an IC(50)(AChE) = 2.9-1.4 M, IC(50)(BChE) = 0.13-0.067 M, and 14-18% propidium displacement at 20 muM. Kin …
End of life for patients with left ventricular assist devices: Insights from INTERMACS.
McIlvennan CK, Grady KL, Matlock DD, Helmkamp LJ, Abshire M, Allen LA. McIlvennan CK, et al. J Heart Lung Transplant. 2019 Apr;38(4):374-381. doi: 10.1016/j.healun.2018.12.008. Epub 2018 Dec 15. J Heart Lung Transplant. 2019. PMID: 30642799
In a multivariable analysis, increased age (RR (risk ratio) 1.06, 95% confidence interval [CI] 1.02 to 1.12, p = 0.01) and destination therapy indication (RR 1.15, 95% CI 1.03 to 1.28, p = 0.01) increased the likelihood of dying outside the hospital. Comparing 3 months pos …
In a multivariable analysis, increased age (RR (risk ratio) 1.06, 95% confidence interval [CI] 1.02 to 1.12, p = 0.01) and destination th …
Effects of a remote-handling-concept-based task-oriented arm training (ReHab-TOAT) on arm-hand skill performance in chronic stroke: a study protocol for a two-armed randomized controlled trial.
Elmanowski J, Seelen H, Geers R, Kleynen M, Verbunt J. Elmanowski J, et al. Trials. 2023 Mar 14;24(1):189. doi: 10.1186/s13063-023-07139-w. Trials. 2023. PMID: 36918922 Free PMC article.
Participants in the control group will receive no additional therapy apart from care as usual. The Fugl-Meyer Assessment (FMA), measuring participants' motor performance of the affected arm, is used as the primary outcome measure. ...Registered on June 22, 2021....
Participants in the control group will receive no additional therapy apart from care as usual. The Fugl-Meyer Assessment (FMA), measu …
[Experimental Study for the Treatment of Asthenozoospermia by Electroacupuncture in Rats].
Jin ZR, Liu BH, Cai J, Jing XH, Zhu B, Xing GG. Jin ZR, et al. Zhen Ci Yan Jiu. 2017 Apr 25;42(2):114-8. Zhen Ci Yan Jiu. 2017. PMID: 29071957 Chinese.
The sperm density, viability, motility, the number of grade A sperm, and grade A+B sperm were examined by computer-assisted sperm analysis. RESULTS: (1) 2 Hz-EA treatment daily in 3 d:compared with the model group and the sham-EA group, 2 Hz-EA treatment once daily had no …
The sperm density, viability, motility, the number of grade A sperm, and grade A+B sperm were examined by computer-assisted sperm ana …
DVH analysis using a transmission detector and model-based dose verification system as a comprehensive pretreatment QA tool for VMAT plans: Clinical experience and results.
Mohamed Yoosuf AB, AlShehri S, Alhadab A, Alqathami M. Mohamed Yoosuf AB, et al. J Appl Clin Med Phys. 2019 Nov;20(11):80-87. doi: 10.1002/acm2.12743. Epub 2019 Oct 11. J Appl Clin Med Phys. 2019. PMID: 31605456 Free PMC article.
In this study, we report our clinical experience with an ionization-based transmission detector and model-based verification system, using DVH analysis, as a comprehensive pretreatment QA tool for complex volumetric modulated arc therapy plans. METHODS AND MATERIALS: Seven …
In this study, we report our clinical experience with an ionization-based transmission detector and model-based verification system, using D …
PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization.
Liu W, Frank SJ, Li X, Li Y, Zhu RX, Mohan R. Liu W, et al. Med Phys. 2013 Feb;40(2):021709. doi: 10.1118/1.4774363. Med Phys. 2013. PMID: 23387732 Free PMC article.
PURPOSE: Robust optimization leads to intensity-modulated proton therapy (IMPT) plans that are less sensitive to uncertainties and superior in terms of organs-at-risk (OARs) sparing, target dose coverage, and homogeneity compared to planning target volume (PTV)-based optim …
PURPOSE: Robust optimization leads to intensity-modulated proton therapy (IMPT) plans that are less sensitive to uncertainties and su …
21 results